1. Home >
  2. Companies >
  3. Life Science >
  4. Switzerland >
  5. G7 Therapeutics AG

G7 Therapeutics AG - Ownership and Business Overview

Life ScienceCompany

G7 Therapeutics AG Ownership

Who owns G7 Therapeutics AG?

G7 Therapeutics AG is owned by Heptares Therapeutics. It was acquired on November 30, 2016.

G7 Therapeutics AG Business Overview

Where is G7 Therapeutics AG headquartered?

G7 Therapeutics AG is headquartered in Schlieren, Switzerland.

What sector is G7 Therapeutics AG in?

G7 Therapeutics AG is a life science company.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Subscribe to Mergr to view all 298 acquisitions of life science companies in 2016, including 35 acquisitions by private equity firms, and 263 by strategics.

G7 Therapeutics AG

Grabenstrasse 11a,
Schlieren, 8952
Switzerland,
www.g7therapeutics.com

G7 Therapeutics AG is a developer of proprietary approaches for stabilising GPCRs (called SaBRE and CHESS), which are different and highly complementary to the StaR® platform developed by Heptares. SaBRE and CHESS are of particular use where the target GPCR is present in very low numbers on cells and the methods are particularly powerful in the numbers of stabilizing mutations that can be identified in a short time for rapidly generating high quality GPCRs.


Company Summary

SECTOR

Life Science

Subsidiary of

Heptares Therapeutics Ltd.

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for G7 Therapeutics AG

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal